Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on APM07. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113264870A reveals a safer, cost-effective route for Apixaban intermediate APM07 using phase transfer catalysis, eliminating dangerous reagents for scalable manufacturing.